Name | Number of supported studies | Average coverage | |
---|---|---|---|
glutamatergic neuron | 3 studies | 31% ± 17% |
Insufficient scRNA-seq data for expression of XYLT2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 1635.01 | 1445 / 1445 | 100% | 28.28 | 183 / 183 |
stomach | 100% | 11749.65 | 359 / 359 | 100% | 22.77 | 286 / 286 |
thymus | 100% | 2015.83 | 653 / 653 | 100% | 30.69 | 604 / 605 |
prostate | 100% | 3044.35 | 245 / 245 | 100% | 35.55 | 501 / 502 |
uterus | 100% | 2312.13 | 170 / 170 | 100% | 31.95 | 458 / 459 |
ovary | 100% | 2531.15 | 180 / 180 | 100% | 23.81 | 429 / 430 |
lung | 100% | 1523.10 | 577 / 578 | 100% | 32.57 | 1154 / 1155 |
breast | 100% | 1699.50 | 459 / 459 | 100% | 32.67 | 1114 / 1118 |
skin | 100% | 2525.52 | 1809 / 1809 | 100% | 28.29 | 470 / 472 |
pancreas | 100% | 1239.47 | 328 / 328 | 99% | 26.76 | 177 / 178 |
intestine | 100% | 1861.14 | 966 / 966 | 99% | 23.36 | 524 / 527 |
kidney | 100% | 1705.53 | 89 / 89 | 99% | 31.83 | 895 / 901 |
bladder | 100% | 2382.00 | 21 / 21 | 99% | 29.66 | 499 / 504 |
brain | 98% | 1238.69 | 2602 / 2642 | 100% | 19.05 | 705 / 705 |
liver | 98% | 847.83 | 221 / 226 | 98% | 17.77 | 398 / 406 |
adrenal gland | 100% | 1842.81 | 257 / 258 | 89% | 13.17 | 205 / 230 |
adipose | 100% | 1436.31 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 23.79 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.15 | 29 / 29 |
spleen | 100% | 2156.25 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 29.96 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 12.06 | 1 / 1 |
blood vessel | 100% | 1555.09 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 98% | 1171.69 | 847 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 91% | 925.54 | 847 / 929 | 0% | 0 | 0 / 0 |
muscle | 91% | 554.78 | 732 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0050650 | Biological process | chondroitin sulfate proteoglycan biosynthetic process |
GO_0030203 | Biological process | glycosaminoglycan metabolic process |
GO_0015012 | Biological process | heparan sulfate proteoglycan biosynthetic process |
GO_0030206 | Biological process | chondroitin sulfate biosynthetic process |
GO_0030210 | Biological process | heparin biosynthetic process |
GO_0006024 | Biological process | glycosaminoglycan biosynthetic process |
GO_0005615 | Cellular component | extracellular space |
GO_0000139 | Cellular component | Golgi membrane |
GO_0030145 | Molecular function | manganese ion binding |
GO_0000287 | Molecular function | magnesium ion binding |
GO_0030158 | Molecular function | protein xylosyltransferase activity |
Gene name | XYLT2 |
Protein name | Xylosyltransferase 2 (EC 2.4.2.26) (Xylosyltransferase II) Xylosyltransferase 2 (EC 2.4.2.26) (Peptide O-xylosyltransferase 1) (Xylosyltransferase II) (XT-II) (XylT-II) Xylosyltransferase 2 |
Synonyms | XT2 UNQ3058/PRO9878 hCG_29612 |
Description | FUNCTION: Catalyzes the first step in the biosynthesis of chondroitin sulfate, heparan sulfate and dermatan sulfate proteoglycans, such as DCN. Transfers D-xylose from UDP-D-xylose to specific serine residues of the core protein. . |
Accessions | ENST00000509778.1 I3L3K2 B4DT06 ENST00000376550.7 Q9H1B5 D6RCT0 H0YB00 ENST00000574840.1 ENST00000017003.7 [Q9H1B5-1] A0A0C4DFW8 ENST00000511654.1 ENST00000507602.5 |